Covid-19: Critical Quality Measures for Pharmaceutical Production

Due to the COVID-19 situation, governments across the world initiated lockdown and quarantines. The lockdowns have a severe impact on pharmaceutical manufacturing across the globe. Some of that include:

• Shortage of raw materials
• Personnel deficiency
• Export bans
• Severe financial damage

All those obstacles lead to a unique manufacturing environment, which may lead to quality deficiencies.

During their talk, Hitendrakumar Shah, the CEO of NADH+ GXP Compliance Services, shared with Yan Kugel his suggestions on how to avoid quality issues during manufacturing, throughout that particular time.

You can watch the podcast in a video format on www.qualistery.com